Citations (196)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (39)
Yukari Koya, Hirotsugu Tanaka, Eiji Yoshimi, Nobuaki Takeshita, Shuji Morita, Hiroki Morio, Kanako Mori, Hiroshi Fushiki & Masazumi Kamohara. (2023) A novel anti-NGF PEGylated Fab’ provides analgesia with lower risk of adverse effects. mAbs 15:1.
Read now
Read now
Renato Vellucci & Diego Fornasari. (2023) Appropriate use of tapentadol: focus on the optimal tapering strategy. Current Medical Research and Opinion 39:1, pages 123-129.
Read now
Read now
Filip Jovanovic, Iulia Pirvulescu, Emilija Knezevic, Kenneth D. Candido & Nebojsa Nick Knezevic. (2021) Comparative safety review of current treatment options for chronic low back pain and unmet needs: a narrative review. Expert Opinion on Drug Safety 20:9, pages 1005-1033.
Read now
Read now
Filippo Migliorini, Nicola Maffulli, Alice Baroncini, Jörg Eschweiler, Markus Tingart & Valentin Quack. (2021) Opioids for chronic low back pain management: a Bayesian network meta-analysis. Expert Review of Clinical Pharmacology 14:5, pages 635-641.
Read now
Read now
Filippo Migliorini, Nicola Maffulli, Jörg Eschweiler, Marcel Betsch, Giovanni Catalano, Arne Driessen, Markus Tingart & Alice Baroncini. (2021) The pharmacological management of chronic lower back pain. Expert Opinion on Pharmacotherapy 22:1, pages 109-119.
Read now
Read now
R. Freynhagen, C. Elling, T. Radic, M. Sohns, H. Liedgens, D. James, R. McCool & M. Edwards. (2021) Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials. Current Medical Research and Opinion 37:1, pages 89-100.
Read now
Read now
Jeffrey Gudin, Andrew G Kaufman & Samyadev Datta. (2020) Are Opioids Needed to Treat Chronic Low Back Pain? A Review of Treatment Options and Analgesics in Development. Journal of Pain Research 13, pages 1007-1022.
Read now
Read now
Filippo Caraci, Flaminia Coluzzi, Franco Marinangeli, Sebastiano Mercadante, Giuseppe Rinonapoli, Patrizia Romualdi, Mariaflavia Nicora & Anthony H. Dickenson. (2020) Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?. Current Medical Research and Opinion 36:6, pages 1015-1024.
Read now
Read now
Donald M. Bushnell, Mona L. Martin, Mariёlle Eerdekens, Annette Christoph, Georg Kralidis & Hiltrud Liedgens. (2020) Pain assessment for chronic lower back pain: performance of the PAL-S and PAL-I patient-reported measures for symptoms and impacts. Current Medical Research and Opinion 36:5, pages 853-863.
Read now
Read now
Filippo Caraci, Flaminia Coluzzi, Franco Marinangeli, Sebastiano Mercadante, Giuseppe Rinonapoli, Patrizia Romualdi, Mariaflavia Nicora & Anthony H. Dickenson. (2020) Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?. Current Medical Research and Opinion 36:5, pages (I)-(XVII).
Read now
Read now
Flaminia Coluzzi, Enrico Polati, Ulderico Freo & Mariagrazia Grilli. (2019) Tapentadol: an effective option for the treatment of back pain. Journal of Pain Research 12, pages 1521-1528.
Read now
Read now
Enrico Polati, Pier Luigi Canonico, Vittorio Schweiger & Massimo Collino. (2019) Tapentadol: an overview of the safety profile. Journal of Pain Research 12, pages 1569-1576.
Read now
Read now
Laura E. Gressler, Drayton A. Hammond & Jacob T. Painter. (2017) Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research. Journal of Pain & Palliative Care Pharmacotherapy 31:3-4, pages 228-236.
Read now
Read now
Bernd Lange, Detlef von Zabern, Christian Elling & Cecile Dubois. (2017) Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled release-controlled studies. Current Medical Research and Opinion 33:8, pages 1413-1422.
Read now
Read now
Nalini Vadivelu, Alice Kai, Benjamin Maslin, Gopal Kodumudi, Aron Legler & Jack M Berger. (2015) Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Therapeutics and Clinical Risk Management 11, pages 95-105.
Read now
Read now
Flaminia Coluzzi, Robert B Raffa, Joseph Pergolizzi, Alessandra Rocco, Pamela Locarini, Natalia Cenfra, Giuseppe Cimino & Consalvo Mattia. (2015) Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease. Journal of Pain Research 8, pages 229-238.
Read now
Read now
Bishal Gyawali, Naomi Hayashi, Hiroaki Tsukuura, Kazunori Honda, Tomoya Shimokata & Yuichi Ando. (2015) Opioid-induced constipation. Scandinavian Journal of Gastroenterology 50:11, pages 1331-1338.
Read now
Read now
Nebojsa Nick Knezevic, Tatiana Tverdohleb, Ivana Knezevic & Kenneth D Candido. (2015) Unique pharmacology of tapentadol for treating acute and chronic pain. Expert Opinion on Drug Metabolism & Toxicology 11:9, pages 1475-1492.
Read now
Read now
Carmelo Scarpignato & Luigi Gatta. (2015) Comparing tapentadol to oxycodone/naloxone combination: building castles in the air. Current Medical Research and Opinion 31:2, pages 335-338.
Read now
Read now
Ece Esin & Suayib Yalcin. (2014) Neuropathic cancer pain: What we are dealing with? How to manage it?. OncoTargets and Therapy 7, pages 599-618.
Read now
Read now
Volker Strick. (2014) Management of severe chronic pain with tapentadol prolonged release – long-term data from pain specialists. Current Medical Research and Opinion 30:10, pages 2085-2092.
Read now
Read now
Sebastiano Mercadante, Giampiero Porzio, Claudio Adile, Federica Aielli, Andrea Cortegiani, Anthony Dickenson & Alessandra Casuccio. (2014) Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain. Current Medical Research and Opinion 30:10, pages 2063-2068.
Read now
Read now
Howard S. Smith, Robert B. Raffa, Joseph V. Pergolizzi, Robert Taylor & Ronald J. Tallarida. (2014) Combining Opioid and Adrenergic Mechanisms for Chronic Pain. Postgraduate Medicine 126:4, pages 98-114.
Read now
Read now
Flaminia Coluzzi & Matteo Ruggeri. (2014) Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain. Current Medical Research and Opinion 30:6, pages 1139-1151.
Read now
Read now
Bansri Desai, Erin Freeman, Ellen Huang, Anna Hung, Edward Knapp, Ian M Breunig, Mary L McPherson & Fadia T Shaya. (2014) Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy. Expert Review of Clinical Pharmacology 7:2, pages 203-209.
Read now
Read now
Nalini Vadivelu, Yili Huang, Brian Mirante, Michael Jacoby, Ferne R Braveman, Roberta L Hines & Raymond Sinatra. (2013) Patient considerations in the use of tapentadol for moderate to severe pain. Drug, Healthcare and Patient Safety 5, pages 151-159.
Read now
Read now
Nalini Sehgal, James Colson & Howard S Smith. (2013) Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy. Expert Review of Neurotherapeutics 13:11, pages 1201-1220.
Read now
Read now
Keiichiro Imanaka, Yushin Tominaga, Mila Etropolski, Ilse van Hove, Masaki Ohsaka, Mikio Wanibe, Keiichiro Hirose & Taka Matsumura. (2013) Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain. Current Medical Research and Opinion 29:10, pages 1399-1409.
Read now
Read now
A. Schwittay, C. Schumann, B. C. Litzenburger & K. Schwenke. (2013) Tapentadol Prolonged Release for Severe Chronic Pain: Results of a Noninterventional Study Involving General Practitioners and Internists. Journal of Pain & Palliative Care Pharmacotherapy 27:3, pages 225-234.
Read now
Read now
Sebastiano Mercadante, Giampiero Porzio, Federica Aielli, Claudio Adile, Lucilla Verna, Corrado Ficorella, Antonello Giarratano & Alessandra Casuccio. (2013) Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids. Current Medical Research and Opinion 29:6, pages 661-666.
Read now
Read now
Sebastiano Mercadante, Giampiero Porzio, Patrizia Ferrera, Federica Aielli, Claudio Adile, Corrado Ficorella, Antonello Giarratano & Alessandra Casuccio. (2012) Tapentadol in cancer pain management: a prospective open-label study. Current Medical Research and Opinion 28:11, pages 1775-1779.
Read now
Read now
Robert Ikenberg, Nadine Hertel, R. Andrew Moore, Marko Obradovic, Garth Baxter, Pete Conway & Hiltrud Liedgens. (2012) Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine. Journal of Medical Economics 15:4, pages 724-736.
Read now
Read now
Ilona Steigerwald, Matthias Müller, Anthony Davies, Daniel Samper, Rainer Sabatowski, Ralf Baron, Sylvie Rozenberg, Anna Szczepanska-Szerej, Antonio Gatti & Hans G. Kress. (2012) Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. Current Medical Research and Opinion 28:6, pages 911-936.
Read now
Read now
Craig T Hartrick & Jose Rafael Rodríguez Hernandez. (2012) Tapentadol for pain: a treatment evaluation. Expert Opinion on Pharmacotherapy 13:2, pages 283-286.
Read now
Read now
Joseph Pergolizzi, Eli Alon, Ralf Baron, Cesare Bonezzi, Jan Dobrogowski, Rafael Gálvez, Troels Jensen, Hans-Georg Kress, Marco AE Marcus, Bart Morlion, Serge Perrot & Rolf-Detlef Treede. (2011) Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?. Journal of Pain Research 4, pages 203-210.
Read now
Read now
Nalini Vadivelu, Alexander Timchenko, Yili Huang & Raymond Sinatra. (2011) Tapentadol extended-release for treatment of chronic pain: a review. Journal of Pain Research 4, pages 211-218.
Read now
Read now
Rob Riemsma, Carol Forbes, Julie Harker, Gill Worthy, Kate Misso, Michael Schäfer, Jos Kleijnen & Steffen Stürzebecher. (2011) Systematic review of tapentadol in chronic severe pain. Current Medical Research and Opinion 27:10, pages 1907-1930.
Read now
Read now
G.E. Bekkering, K. Soares-Weiser, K. Reid, A.G. Kessels, A. Dahan, R.D. Treede & J. Kleijnen. (2011) Can morphine still be considered to be the standard for treating chronic pain? A systematic review including pair-wise and network meta-analyses. Current Medical Research and Opinion 27:7, pages 1477-1491.
Read now
Read now
Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro, Akiko Okamoto, Robert Lange, Juergen Haeussler & Christine Rauschkolb. (2011) Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Current Medical Research and Opinion 27:1, pages 151-162.
Read now
Read now
Articles from other publishers (157)
Qiuzhe Chen, Chris G. Maher, Christopher S. Han, Christina Abdel Shaheed, Chung-Wei Christine Lin, Eileen M. Rogan & Gustavo C. Machado. (2023) Continued Opioid Use and Adverse Events Following Provision of Opioids for Musculoskeletal Pain in the Emergency Department: A Systematic Review and Meta-Analysis. Drugs 83:16, pages 1523-1535.
Crossref
Crossref
S Naveen, P Elango & Ramya S. (2023) An Open-Label, Randomized, Parallel-Group Study to Assess the Safety, Efficacy, and Tolerability of Tapentadol Versus Tramadol in Outpatients with Moderate to Severe Chronic Low Back Pain at a Tertiary Care Hospital in South India. Biomedical and Pharmacology Journal 16:2, pages 1037-1046.
Crossref
Crossref
Filippo Migliorini, Raju Vaishya, Gaetano Pappalardo, Marco Schneider, Andreas Bell & Nicola Maffulli. (2023) Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain. BMC Musculoskeletal Disorders 24:1.
Crossref
Crossref
Stephanie C Ternel (Lebret). (2023) Considerations for perioperative opioid analgesic stewardship in Australia: a focus on tapentadol. Pain Management 13:5, pages 299-307.
Crossref
Crossref
Ronald J. Feise, Stephanie Mathieson, Rodger S. Kessler, Corey Witenko, Fabio Zaina & Benjamin T. Brown. (2023) Benefits and harms of treatments for chronic nonspecific low back pain without radiculopathy: systematic review and meta-analysis. The Spine Journal 23:5, pages 629-641.
Crossref
Crossref
Beatriz Orts Jorquera, Javier Muriel Serrano & Ana María Peiró Peiró. (2023) Farmacogenética y respuesta analgésica: hacia una medicina personalizada con análisis de las diferencias por sexo. Revista de la Sociedad Española del Dolor.
Crossref
Crossref
Emma A. Craige, Scott D. Tagliaferri, Sally A. Ferguson, Hannah Scott, Daniel L. Belavy, Dayna F. Easton, Paul Buntine, Aamir R. Memon, Patrick J. Owen & Grace E. Vincent. (2023) Effects of pharmacotherapy on sleep-related outcomes in adults with chronic low back pain: a systematic review and meta-analysis of randomised controlled trials. eClinicalMedicine 55, pages 101749.
Crossref
Crossref
Jae-Young Hong, Kwang-Sup Song, Jae Hwan Cho, Jae Hyup Lee & Nack Hwan Kim. (2022) An Updated Overview of Low Back Pain Management. Asian Spine Journal 16:6, pages 968-982.
Crossref
Crossref
James M. Puterflam, Julian J. Comis, Qianwen Lan, Chen Liu, Adam J. Lipschitz, Ronald R. Grunstein, Paulo H. Ferreira & Christopher J. Gordon. (2022) The short-term effects of opioid and non-opioid pharmacotherapies on sleep in people with chronic low back pain: A systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews 65, pages 101672.
Crossref
Crossref
Atefeh Noori, Behnam Sadeghirad, Li Wang, Reed A.C. Siemieniuk, Mostafa Shokoohi, Elena Kum, Mark Jeddi, Luis Montoya, Patrick J. Hong, Edward Zhou, Rachel J. Couban, David N. Juurlink, Lehana Thabane, Mohit Bhandari, Gordon H. Guyatt & Jason W. Busse. (2022) Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials. British Journal of Anaesthesia 129:3, pages 394-406.
Crossref
Crossref
Jonathan L. Fu & Michael D. Perloff. (2022) Pharmacotherapy for Spine-Related Pain in Older Adults. Drugs & Aging 39:7, pages 523-550.
Crossref
Crossref
Edris Nury, Christine Schmucker, Blin Nagavci, Edith Motschall, Kai Nitschke, Erika Schulte, Odette Wegwarth & Joerg J. Meerpohl. (2022) Efficacy and safety of strong opioids for chronic noncancer pain and chronic low back pain: a systematic review and meta-analyses. Pain 163:4, pages 610-636.
Crossref
Crossref
Michael A Überall, Christian Elling, Christoph Eibl, Gerhard HH Müller-Schwefe, Claudia Lefeber, Myriam Heine & Birgit Heckes. (2022) Tapentadol prolonged release in patients with chronic low back pain: real-world data from the German Pain eRegistry. Pain Management 12:2, pages 211-227.
Crossref
Crossref
Osamu Shirado, Yoshiyasu Arai, Tetsuhiro Iguchi, Shiro Imagama, Mamoru Kawakami, Takuya Nikaido, Tadanori Ogata, Sumihisa Orita, Daisuke Sakai, Kimiaki Sato, Masahiko Takahata, Katsushi Takeshita, Takashi Tsuji, Kei Ando, Yoshiyasu Arai, Teruaki Endo, Hironari Fukuda, Masafumi Goto, Hiroshi Hashidume, Masayuki Hino, Yohei Ide, Tetsuhiro Iguchi, Shiro Imagama, Hirokazu Inoue, Taro Inoue, Yuyu Ishimoto, Kenyu Ito, Sadayuki Ito, Masumi Iwabuchi, Shoji Iwahashi, Hiroshi Iwasaki, Ryohei Kagotani, Shunsuke Kanbara, Kinshi Kato, Mamoru Kawakami, Atsushi Kimura, Tomoko Kitagawa, Hiroshi Kobayashi, Kazuyoshi Kobayashi, Jun Komatsu, Hiroyuki Koshimizu, Masaaki Machino, Tsunemasa Matsubara, Yu Matsukura, Akihito Minamide, Masakazu Minetama, Kenji Mizokami, Tadao Morino, Masayoshi Morozumi, Keiji Nagata, Ichiro Nakae, Masafumi Nakagawa, Yukihiro Nakagawa, Takuya Nikaido, Tadanori Ogata, Sumihisa Orita, Kyotaro Ota, Daisuke Sakai, Kenichiro Sakai, Rikiya Saruwatari, Shinichi Sasaki, Kimiaki Sato, Takahiro Shimazaki, Osamu Shirado, Yasuyuki Shiraishi, Masahiko Takahata, Masanari Takami, Katsushi Takeshita, Satoshi Tanaka, Masatoshi Teraguchi, Ryoji Tominaga, Masaki Tomori, Ichiro Torigoe, Takashi Tsuji, Mikito Tsushima, Shunji Tsutsui, Kazuyuki Watanabe, Hiroshi Yamada, Kei Yamada, Hidetoshi Yamaguchi, Kimiaki Yokosuka, Takanori Yoshida, Tatsuhiro Yoshida, Masato Yuasa & Yasutsugu Yugawa. (2022) Formulation of Japanese Orthopaedic Association (JOA) clinical practice guideline for the management of low back pain- the revised 2019 edition. Journal of Orthopaedic Science 27:1, pages 3-30.
Crossref
Crossref
Ziqin Cao, Qiangxiang Li, Jia Guo, Yajia Li & Jianhuang Wu. (2021) Is Targeting Nerve Growth Factor Antagonist a New Option for Pharmacologic Treatment of Low Back Pain? A Supplemental Network Meta-Analysis of the American College of Physicians Guidelines. Frontiers in Pharmacology 12.
Crossref
Crossref
Lucien Roulet, Victoria Rollason, Jules Desmeules & Valérie Piguet. (2021) Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients. Drugs 81:11, pages 1257-1272.
Crossref
Crossref
Melinda Járomi, Brigitta Szilágyi, Anita Velényi, Eleonóra Leidecker, Bence László Raposa, Márta Hock, Petra Baumann, Pongrác Ács & Alexandra Makai. (2021) Assessment of health-related quality of life and patient’s knowledge in chronic non-specific low back pain. BMC Public Health 21:S1.
Crossref
Crossref
Cesar Margarit Ferri, Silvia Natoli, Paz Sanz-Ayan, Alberto Magni, Carlos Guerrero, Argelia Lara-Solares, Hiltrud Liedgens, Guido Thömmes & Ravi Karra. (2021)
Quality of life and functional outcomes with tapentadol prolonged release in chronic musculoskeletal pain:
post hoc
analysis
. Pain Management 11:2, pages 173-187.
Crossref
Crossref
Jitka FRICOVÁ, Helena LAINCZOVÁ, J NEDVÍDEK & R ROKYTA. (2021) Effect of Tapentadol on Experimental Model of Orofacial Pain – a Pilot Study. Physiological Research, pages S533-S537.
Crossref
Crossref
Nathalie Erpelding, Kathryn Evans, Ryan K. Lanier, Harrison Elder & Nathaniel P. Katz. (2020) Placebo Response Reduction and Accurate Pain Reporting Training Reduces Placebo Responses in a Clinical Trial on Chronic Low Back Pain. The Clinical Journal of Pain 36:12, pages 950-954.
Crossref
Crossref
Barbara Kosińska, Paweł Turczyn, Krzysztof Wesołowski, Beata Tarnacka & Małgorzata Malec-Milewska. (2020) Central sensitization in chronic lumbar spine pain – possibilities of therapeutic interventions. BÓL 21:2, pages 45-53.
Crossref
Crossref
Tine van de Donk, Jurjan van Cosburgh, Tom van Dasselaar, Monique van Velzen, Asbjørn Mohr Drewes, Albert Dahan & Marieke Niesters. (2020) Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitization. PAIN Reports 5:6, pages e877.
Crossref
Crossref
D. Scott Kreiner, Paul Matz, Christopher M. Bono, Charles H. Cho, John E. Easa, Gary Ghiselli, Zoher Ghogawala, Charles A. Reitman, Daniel K. Resnick, William C. WattersIIIIII, Thiru M. Annaswamy, Jamie Baisden, Walter S. Bartynski, Shay Bess, Randall P. Brewer, R. Carter Cassidy, David S. Cheng, Sean D. Christie, Norman B. Chutkan, Bernard Allan Cohen, Simon Dagenais, Dennis E. Enix, Paul Dougherty, S. Raymond Golish, Padma Gulur, Steven W. Hwang, Cumhur Kilincer, Jeffrey A. King, Adam C. Lipson, Anthony J. Lisi, Richard J. Meagher, John E. O'Toole, Paul Park, Murat Pekmezci, Daniel R. Perry, Ravi Prasad, David A. Provenzano, Kris E. Radcliff, Gazanfar Rahmathulla, Tom E. Reinsel, Robert L. RichJr.Jr., Daniel S. Robbins, Karie A. Rosolowski, Jonathan N. Sembrano, Anil K. Sharma, Alison A. Stout, Christopher K. Taleghani, Ryan A. Tauzell, Terry Trammell, Yakov Vorobeychik & Amy M. Yahiro. (2020) Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of low back pain. The Spine Journal 20:7, pages 998-1024.
Crossref
Crossref
Hannah-Rose Tucker, Katie Scaff, Tess McCloud, Kimberly Carlomagno, Kathleen Daly, Alessandra Garcia & Chad E Cook. (2020) Harms and benefits of opioids for management of non-surgical acute and chronic low back pain: a systematic review. British Journal of Sports Medicine 54:11, pages 664-664.
Crossref
Crossref
Frank Petzke, Petra Klose, Patrick Welsch, Claudia Sommer & Winfried Häuser. (2019) Opioids for chronic low back pain: An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks of double‐blind duration. European Journal of Pain 24:3, pages 497-517.
Crossref
Crossref
Tyler E. Gaston, Jerzy P. Szaflarski, Allen C. Bowling, Ying Liu, Tristan Seawalt, Maureen A. Leehey, E. Lee Nelson, Sharad Rajpal, Alan T. Villavicencio, Andrew Bauer & Sigita Burneikiene. 2020. Cannabis in Medicine. Cannabis in Medicine
231
312
.
Dermot P. Maher, Bunty J. Shah & Yakov Vorobeychik. 2020. Spine Pain Care. Spine Pain Care
231
257
.
Robert A. SwarmJudith A. PaiceDoralina L. AnghelescuMadhuri AreJustine Yang BruceSorin BugaMarcin ChwistekCharles CleelandDavid CraigEllin GaffordHeather GreenleeEric HansenArif H. KamalMihir M. KamdarSusan LeGrandSean MackeyM. Rachel McDowellNatalie MorylLisle M. NabellSuzanne Nesbit, Nina O’ConnorMichael W. RabowElizabeth RickersonRebecca ShatskyJill SindtSusan G. UrbaJeanie M. Youngwerth, Lydia J. Hammond & Lisa A. Gurski. (2019) Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 17:8, pages 977-1007.
Crossref
Crossref
Ramagonolla Kranthikumar, Prathama S. Mainkar, Genji Sukumar, Rambabu Chegondi & Srivari Chandrasekhar. (2019) Tetrahydrothiopyran-4-one as Five-Carbon Source for Scalable Synthesis of (±)-Tapentadol. Organic Process Research & Development 23:7, pages 1369-1373.
Crossref
Crossref
William L. Hasler, Laura A. Wilson, Linda A. Nguyen, William J. Snape, Thomas L. Abell, Kenneth L. Koch, Richard W. McCallum, Pankaj J. Pasricha, Irene Sarosiek, Gianrico Farrugia, Madhusudan Grover, Linda A. Lee, Laura Miriel, James Tonascia, Frank A. Hamilton, Henry P. Parkman, Pankaj Jay Pasricha, John Clarke, Yale Kim, Linda Nguyen, Nighat Ullah, William Snape, Nata DeVole, Mary Greene, Candice Lee, Courtney Ponsetto, Katerina Shetler, Henry P. Parkman, Steven Kantor, Vanessa Lytes, Amiya Palit, Kellie Simmons, Richard W. McCallum, Reza Hejazi, Kathy Roeser, Irene Sarosiek, Denise Vasquez, Natalia Vega, Thomas Abell, Karen Beatty, Lisa Hatter, Ronna Howard, Lindsay Nowotny, Shou Tang, Om S. Amin, Olivia Henry, Archana Kedar, Valerie McNair, Susanne Pruett, Margaret Smith, Danielle Spree, William Hasler, Michelle Castle, Radoslav Coleski, Sophanara Wootten, Kenneth Koch, Lynn Baxter, Anya Brown, Samantha Culler, Judy Hooker, Paula Stuart, Gianrico Farrugia, Madhusudan Grover, Cheryl Bernard, Jorge Calles-Escandon, Jose Serrano, Frank Hamilton, Steven James, Rebecca Torrance, Rebekah Van Raaphorst, James Tonascia, Patricia Belt, Erin Corless Hallinan, Ryan Colvin, Michele Donithan, Mika Green, Milana Isaacson, Wana Kim, Linda Lee, Patrick May, Laura Miriel, Alice Sternberg, Mark Van Natta, Ivana Vaughn, Laura Wilson & Katherine Yates. (2019) Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis. Clinical Gastroenterology and Hepatology 17:7, pages 1285-1294.e1.
Crossref
Crossref
Christopher Ll. Morgan, Sara Jenkins-Jones, Craig Currie & Garth Baxter. (2019) Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study. Advances in Therapy 36:6, pages 1412-1425.
Crossref
Crossref
Francesca F. Caputi, Mariaflavia Nicora, Roberto Simeone, Sanzio Candeletti & Patrizia Romualdi. (2019) Tapentadol: an analgesic that differs from classic opioids due to its noradrenergic mechanism of action. Minerva Medica 110:1.
Crossref
Crossref
Jason W. Busse, Li Wang, Mostafa Kamaleldin, Samantha Craigie, John J. Riva, Luis Montoya, Sohail M. Mulla, Luciane C. Lopes, Nicole Vogel, Eric Chen, Karin Kirmayr, Kyle De Oliveira, Lori Olivieri, Alka Kaushal, Luis E. Chaparro, Inna Oyberman, Arnav Agarwal, Rachel Couban, Ludwig Tsoi, Tommy Lam, Per Olav Vandvik, Sandy Hsu, Malgorzata M. Bala, Stefan SchandelmaierAnne Scheidecker, Shanil Ebrahim, Vahid Ashoorion, Yasir Rehman, Patrick J. Hong, Stephanie Ross, Bradley C. Johnston, Regina KunzXin Sun, Norman Buckley, Daniel I. Sessler & Gordon H. Guyatt. (2018) Opioids for Chronic Noncancer Pain. JAMA 320:23, pages 2448.
Crossref
Crossref
Emma D. Deeks. (2018) Tapentadol Prolonged Release: A Review in Pain Management. Drugs 78:17, pages 1805-1816.
Crossref
Crossref
Robert B. Raffa, Christian Elling & Thomas M. Tzschentke. (2018) Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’. Advances in Therapy 35:10, pages 1471-1484.
Crossref
Crossref
Jarosław Woroń. (2018) Opioid analgesics in the pharmacotherapy of pain, when in practice it is worth choosing tapentadol. BÓL 19:1, pages 51-53.
Crossref
Crossref
Jessie S Channell & Stephan Schug. (2018) Toxicity of tapentadol: a systematic review. Pain Management 8:5, pages 327-339.
Crossref
Crossref
Renata Zajączkowska, Barbara Przewłocka, Magdalena Kocot-Kępska, Joanna Mika, Wojciech Leppert & Jerzy Wordliczek. (2018) Tapentadol – A representative of a new class of MOR-NRI analgesics. Pharmacological Reports 70:4, pages 812-820.
Crossref
Crossref
Thomas S. W. Park, Andy Kuo & Maree T. Smith. (2018) Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data. Inflammopharmacology 26:4, pages 881-898.
Crossref
Crossref
Joseph V. PergolizziJrJr, Robert TaylorJrJr, Jo Ann LeQuang, Robert B. Raffa & John Bisney. (2018) Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain. Pain and Therapy 7:1, pages 37-57.
Crossref
Crossref
Seema Gupta, Nusrat Kreem Bhat, Shivani Rani, Farid Hussain & Rajesh Kumar. (2018) COMPARATIVE EFFICACY AND SAFETY OF TAPENTADOL AND TRAMADOL IN PATIENTS WITH MODERATE TO SEVERE CHRONIC LOW BACK PAIN: A PROSPECTIVE, RANDOMIZED, OPEN-LABELTRIAL AT TERTIARY CARE TEACHING HOSPITAL IN NORTH INDIA. Journal of Evidence Based Medicine and Healthcare 5:6, pages 542-548.
Crossref
Crossref
L. Arendt‐Nielsen, B. Morlion, S. Perrot, A. Dahan, A. Dickenson, H.G. Kress, C. Wells, D. Bouhassira & A. Mohr Drewes. (2017) Assessment and manifestation of central sensitisation across different chronic pain conditions. European Journal of Pain 22:2, pages 216-241.
Crossref
Crossref
Filipa Pereira, Sergio Azevedo, Helena Magalhaes, Claudia Vieira, Deolinda Pereira & Maria Fragoso. (2018) Three case reports of chronic pain with neuropathic component - the importance of individualized therapy. European Journal of Medical Case Reports, pages 91-94.
Crossref
Crossref
Mark Holtsman & Charity Hale. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine
385
388.e1
.
Ariane Stollenwerk, Melanie Sohns, Fabian Heisig, Christian Elling & Detlef von Zabern. (2017) Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic. Advances in Therapy 35:1, pages 12-30.
Crossref
Crossref
R. van der Schrier, K. Jonkman, M. van Velzen, E. Olofsen, A M Drewes, A. Dahan & M. Niesters. (2017) An experimental study comparing the respiratory effects of tapentadol and oxycodone in healthy volunteers. British Journal of Anaesthesia 119:6, pages 1169-1177.
Crossref
Crossref
Andrea L. NicolRobert W. HurleyHonorio T. Benzon. (2017) Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials. Anesthesia & Analgesia 125:5, pages 1682-1703.
Crossref
Crossref
Alberto Carmona-Bayonas, Paula Jiménez Fonseca & Juan Virizuela Echaburu. (2017) Tapentadol for Cancer Pain Management: A Narrative Review. Pain Practice 17:8, pages 1075-1088.
Crossref
Crossref
Robert Morlock & Glenn D. Braunstein. (2017) Pharmacoeconomics of genotyping-based treatment decisions in patients with chronic pain. PAIN Reports 2:5, pages e615.
Crossref
Crossref
Michael Camilleri, Anthony Lembo & David A. Katzka. (2017) Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits. Clinical Gastroenterology and Hepatology 15:9, pages 1338-1349.
Crossref
Crossref
Jae-Young Hong, Kwang-Sup Song, Jae Hwan Cho & Jae Hyup Lee. (2017) An Updated Overview of Low Back Pain Management in Primary Care. Asian Spine Journal 11:4, pages 653-660.
Crossref
Crossref
Ralf Baron, Leopold Eberhart, Kai-Uwe Kern, Stefan Regner, Roman Rolke, Christian Simanski & Thomas Tölle. (2017) Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data. Pain Practice 17:5, pages 678-700.
Crossref
Crossref
Nalini Vadivelu, Daniel Chang, Erik M. Helander, Gregory J. Bordelon, Alice Kai, Alan D. Kaye, Dora Hsu, Daniel Bang & Inderjeet Julka. (2017) Ketorolac, Oxymorphone, Tapentadol, and Tramadol. Anesthesiology Clinics 35:2, pages e1-e20.
Crossref
Crossref
Kubra Boza, Gerry McKay & Andrea Llano. (2017) Tapentadol modified release. Practical Diabetes 34:4, pages 141-142.
Crossref
Crossref
Alan T. Villavicencio, E. Lee Nelson, Vinod Kantha & Sigita Burneikiene. (2017) Prediction based on preoperative opioid use of clinical outcomes after transforaminal lumbar interbody fusions. Journal of Neurosurgery: Spine 26:2, pages 144-149.
Crossref
Crossref
Stefan Müller-Lissner, Gabrio Bassotti, Benoit Coffin, Asbjørn Mohr Drewes, Harald Breivik, Elon Eisenberg, Anton Emmanuel, Françoise Laroche, Winfried Meissner & Bart Morlion. (2016) Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline. Pain Medicine, pages pnw255.
Crossref
Crossref
David Sibbritt, Romy Lauche, Tobias Sundberg, Wenbo Peng, Craig Moore, Alex Broom, Emma Kirby & Jon Adams. (2016) Severity of back pain may influence choice and order of practitioner consultations across conventional, allied and complementary health care: a cross-sectional study of 1851 mid-age Australian women. BMC Musculoskeletal Disorders 17:1.
Crossref
Crossref
Allen A. Lee & William L. Hasler. (2016) Opioids and GI Motility—Friend or Foe?. Current Treatment Options in Gastroenterology 14:4, pages 478-494.
Crossref
Crossref
Helen Gaskell, Sheena Derry, Cathy Stannard & R Andrew Moore. (2016) Oxycodone for neuropathic pain in adults. Cochrane Database of Systematic Reviews 2016:7.
Crossref
Crossref
Christina Abdel Shaheed, Chris G. Maher, Kylie A. Williams, Richard Day & Andrew J. McLachlan. (2016) Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain. JAMA Internal Medicine 176:7, pages 958.
Crossref
Crossref
Ralf Baron, Jan‐Peter Jansen, Andreas Binder, Manuel Pombo‐Suarez, Lieven Kennes, Matthias Müller, Dietmar Falke & Ilona Steigerwald. (2015)
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (
PR
) Compared with Oxycodone/Naloxone
PR
in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial
. Pain Practice 16:5, pages 600-619.
Crossref
Crossref
Ralf Baron, Rudolf Likar, Emilio Martin‐Mola, Francisco J. Blanco, Lieven Kennes, Matthias Müller, Dietmar Falke & Ilona Steigerwald. (2015)
Effectiveness of Tapentadol Prolonged Release (
PR
) Compared with Oxycodone/Naloxone
PR
for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐Label, Phase 3b/4 Study
. Pain Practice 16:5, pages 580-599.
Crossref
Crossref
Jorge Bacallao, Alfonso J. Casado, Ralf Baron & Ilona Steigerwald. (2016) Methodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release. Pain Practice 16:3.
Crossref
Crossref
M. Gaubitz, T. Schiffer, C. Holm, E. Richter, W. Pisternick‐Ruf & T. Weiser. (2015) Efficacy and safety of nicoboxil/nonivamide ointment for the treatment of acute pain in the low back – A randomized, controlled trial. European Journal of Pain 20:2, pages 263-273.
Crossref
Crossref
Ross A. HauserJohanna B. LacknerDanielle Steilen-MatiasDavid K. Harris. (2016) A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 9, pages CMAMD.S39160.
Crossref
Crossref
Keiichiro Imanaka, Takashi Yoshimura, Yushin Tominaga, Hiromi Koga & Keiichiro Hirose. (2016) A Multicenter, Open-label Study of Tapentadol Extended-release Tablets in Opioid-naïve and Opioid-switching Subjects with Moderate to Severe Cancer Pain. Palliative Care Research 11:2, pages 147-155.
Crossref
Crossref
Keiichiro Imanaka, Takashi Yoshimura, Yushin Tominaga, Hiromi Koga & Keiichiro Hirose. (2016) 8-week Safety Profile of Tapentadol Extended Release Tablets Switched from Other Opioids for Well-controlled, Moderate to Severe, Chronic Malignant Tumor-related Pain: Constipation, Nausea, Vomiting and Somnolence. Palliative Care Research 11:1, pages 116-122.
Crossref
Crossref
Escarlata López Ramírez, D. M. Muñoz Carmona, J. Contreras Martínez & A. de la Torre Luque. (2016) Tapentadol in the management of opioid-naïve patients with cancer pain. Revista de la Sociedad Española del Dolor 23.
Crossref
Crossref
Monika Thomm. 2016. Schmerzmanagement in der Pflege. Schmerzmanagement in der Pflege
23
94
.
Mellar Davis & Pamela Gamier. (2015) New Options in Constipation Management. Current Oncology Reports 17:12.
Crossref
Crossref
Jakob Lykke Poulsen, Christina Brock, Anne Estrup Olesen, Matias Nilsson & Asbjørn Mohr Drewes. (2015) Evolving paradigms in the treatment of opioid-induced bowel dysfunction. Therapeutic Advances in Gastroenterology 8:6, pages 360-372.
Crossref
Crossref
Joshua T. Anderson, Arnold R. Haas, Rick Percy, Stephen T. Woods, Uri M. Ahn & Nicholas U. Ahn. (2015) Chronic Opioid Therapy After Lumbar Fusion Surgery for Degenerative Disc Disease in a Workers’ Compensation Setting. Spine 40:22, pages 1775-1784.
Crossref
Crossref
Robert Buynak, Stephen A. Rappaport, Kevin Rod, Pierre Arsenault, Fabian Heisig, Christine Rauschkolb & Mila Etropolski. (2015) Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial. Clinical Therapeutics 37:11, pages 2420-2438.
Crossref
Crossref
Mike Durkin, Jacqueline Pesa, Jessica Lopatto, Rachel Halpern, Damon Van Voorhis & Stephanie Korrer. (2015) Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR. Journal of Health Economics and Outcomes Research 2:2, pages 221-232.
Crossref
Crossref
Nathaniel P. Katz, Joy Mou, Jeremiah Trudeau, Jim Xiang, Gary Vorsanger, Camille Orman & Myoung Kim. (2015) Development and preliminary validation of an integrated efficacy–tolerability composite measure for the evaluation of analgesics. Pain 156:7, pages 1357-1365.
Crossref
Crossref
Ralf Baron, Emilio Martin‐Mola, Matthias Müller, Cecile Dubois, Dietmar Falke & Ilona Steigerwald. (2014)
Effectiveness and Safety of Tapentadol Prolonged Release (
PR
) Versus a Combination of Tapentadol
PR
and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study
. Pain Practice 15:5, pages 455-470.
Crossref
Crossref
Ralf Baron, Uwe Kern, Matthias Müller, Cecile Dubois, Dietmar Falke & Ilona Steigerwald. (2014) Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open‐label Continuation Arm of a Randomized Phase 3b Study. Pain Practice 15:5, pages 471-486.
Crossref
Crossref
Felicity C. Veal & Gregory M. Peterson. (2015) Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?. Drugs & Aging 32:6, pages 419-426.
Crossref
Crossref
Boaz G. Samolsky Dekel, Sivia Ghedini, Alberto Gori, Alessio Vasarri, GianFranco Di Nino & Rita M. Melotti. (2015) Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain. Pain and Therapy 4:1, pages 107-117.
Crossref
Crossref
Uwe Richter, Susanne Waldmann-Rex & Ute Lehmann. (2014) Konsekutive Umstellung auf Tapentadol PR verbessert Analgesie und Lebensqualität bei Patienten mit starken und chronischen Schmerzen unter Tramadol > 300 mg/dConversion to tapentadol PR improves analgesia and quality of life in patients with severe and chronic pain despite using tramadol > 300 mg/d. Wiener klinische Wochenschrift 127:11-12, pages 477-487.
Crossref
Crossref
João Santos, Joana Alarcão, Filipa Fareleira, António Vaz Carneiro & João Costa. (2015) Tapentadol for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews 2020:5.
Crossref
Crossref
Sherwyn Schwartz, Mila S. Etropolski, Douglas Y. Shapiro, Christine Rauschkolb, Aaron I. Vinik, Bernd Lange, Kimberly Cooper, Ilse Van Hove & Juergen Haeussler. (2014) A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy. Clinical Drug Investigation 35:2, pages 95-108.
Crossref
Crossref
F. Petzke, P. Welsch, P. Klose, R. Schaefert, C. Sommer & W. Häuser. (2014) Opioide bei chronischem KreuzschmerzOpioids in chronic low back pain. Der Schmerz 29:1, pages 60-72.
Crossref
Crossref
R. Lauche, P. Klose, L. Radbruch, P. Welsch & W. Häuser. (2014) Opioide bei chronischen nicht-tumorbedingten Schmerzen – gibt es Unterschiede?Opioids in chronic noncancer pain—are opioids different?. Der Schmerz 29:1, pages 73-84.
Crossref
Crossref
Emily C. McNaughton, Ryan A. Black, Sarah E. Weber & Stephen F. Butler. (2015) Assessing Abuse Potential of New Analgesic Medications Following Market Release: An Evaluation of Internet Discussion of Tapentadol Abuse. Pain Medicine 16:1, pages 131-140.
Crossref
Crossref
Stephen F. Butler, Emily C. McNaughton & Ryan A. Black. (2015) Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse Treatment. Pain Medicine 16:1, pages 119-130.
Crossref
Crossref
Deepika Thakur, Sara Dickerson, Mohit Kumar Bhutani & Rod Junor. (2015) Impact of Prolonged-release Oxycodone/Naloxone on Outcomes Affecting Patients' Daily Functioning in Comparison With Extended-release Tapentadol: A Systematic Review. Clinical Therapeutics 37:1, pages 212-224.
Crossref
Crossref
Manuel J. Sánchez del Águila, Michael Schenk, Kai-Uwe Kern, Tanja Drost & Ilona Steigerwald. (2015) Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain. Clinical Therapeutics 37:1, pages 94-113.
Crossref
Crossref
Martina Sendera & Alice SenderaMartina Sendera & Alice Sendera. 2015. Chronischer Schmerz. Chronischer Schmerz
105
111
.
Christoph Ostgathe & Bernd-Oliver Maier. 2015. Palliative Care in Oncology. Palliative Care in Oncology
59
78
.
M. Soledad Cepeda, Daniel Fife, Mary A. Kihm, Greg Mastrogiovanni & Yingli Yuan. (2014) Comparison of the Risks of Shopping Behavior and Opioid Abuse Between Tapentadol and Oxycodone and Association of Shopping Behavior and Opioid Abuse. The Clinical Journal of Pain 30:12, pages 1051-1056.
Crossref
Crossref
Peter Holzer. (2014) Pharmacology of Opioids and their Effects on Gastrointestinal Function. The American Journal of Gastroenterology Supplements 2:1, pages 9-16.
Crossref
Crossref
Charles E Argoff & Eugene R Viscusi. (2014) The Use of Opioid Analgesics for Chronic Pain: Minimizing the Risk for Harm. The American Journal of Gastroenterology Supplements 2:1, pages 3-8.
Crossref
Crossref
A. Cowan, R.B. Raffa, C.S. Tallarida, R.J. Tallarida, T. Christoph, W. Schröder & T.M. Tzschentke. (2014) Lack of synergistic interaction between the two mechanisms of action of tapentadol in gastrointestinal transit. European Journal of Pain 18:8, pages 1148-1156.
Crossref
Crossref
Aaron I. Vinik, Douglas Y. Shapiro, Christine Rauschkolb, Bernd Lange, Keith Karcher, Deborah Pennett & Mila S. Etropolski. (2014) A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy. Diabetes Care 37:8, pages 2302-2309.
Crossref
Crossref
David M. Biondi, Jim Xiang, Mila Etropolski & Bruce Moskovitz. (2014) Evaluation of Blood Pressure and Heart Rate in Patients with Hypertension Who Received Tapentadol Extended Release for Chronic Pain: A Post Hoc, Pooled Data Analysis. Clinical Drug Investigation 34:8, pages 565-576.
Crossref
Crossref
Kurt Ruetzler, Constance J. Blome, Sabine Nabecker, Natalya Makarova, Henrik Fischer, Harald Rinoesl, Georg Goliasch, Daniel I. Sessler & Herbert Koinig. (2013) A randomised trial of oral versus intravenous opioids for treatment of pain after cardiac surgery. Journal of Anesthesia 28:4, pages 580-586.
Crossref
Crossref
M. Niesters, P.L. Proto, L. Aarts, E.Y. Sarton, A.M. Drewes & A. Dahan. (2014) Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. British Journal of Anaesthesia 113:1, pages 148-156.
Crossref
Crossref
Keiichiro Imanaka, Yushin Tominaga, Mila Etropolski, Hiroki Ohashi, Keiichiro Hirose & Taka Matsumura. (2014) Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release. Clinical Drug Investigation 34:7, pages 501-511.
Crossref
Crossref
Helen Gaskell, R Andrew Moore, Sheena Derry & Cathy Stannard. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Richard L. Rauck, Srinivas Nalamachu, James E. Wild, George S. Walker, Cynthia Y. Robinson, Charles S. Davis & Stephen J. Farr. (2014) Single-Entity Hydrocodone Extended-Release Capsules in Opioid-Tolerant Subjects with Moderate-to-Severe Chronic Low Back Pain: A Randomized Double-Blind, Placebo-Controlled Study. Pain Medicine 15:6, pages 975-985.
Crossref
Crossref
Rainer Sabatowski, Rüdiger Scharnagel, Anne Gyllensvärd & Ilona Steigerwald. (2014) Driving Ability in Patients with Severe Chronic Low Back or Osteoarthritis Knee Pain on Stable Treatment with Tapentadol Prolonged Release: A Multicenter, Open-label, Phase 3b Trial. Pain and Therapy 3:1, pages 17-29.
Crossref
Crossref
François Mercier, Laurent Claret, Klaas Prins & René Bruno. (2014) A Model-Based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-Malignant Pain. Pain and Therapy 3:1, pages 31-44.
Crossref
Crossref
Mila Etropolski, Brigitte Kuperwasser, Maren Flügel, Thomas Häufel, Bernd Lange, Christine Rauschkolb & Frank Laschewski. (2014) Safety and Tolerability of Tapentadol Extended Release in Moderate to Severe Chronic Osteoarthritis or Low Back Pain Management: Pooled Analysis of Randomized Controlled Trials. Advances in Therapy 31:6, pages 604-620.
Crossref
Crossref
Bernard Favrat, Katharina Balck, Christian Breymann, Michael Hedenus, Thomas Keller, Anna Mezzacasa & Christoph Gasche. (2014) Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women – PREFER a Randomized, Placebo-Controlled Study. PLoS ONE 9:4, pages e94217.
Crossref
Crossref
Luis Enrique Chaparro, Andrea D. Furlan, Amol Deshpande, Angela Mailis-Gagnon, Steven Atlas & Dennis C. Turk. (2014) Opioids Compared With Placebo or Other Treatments for Chronic Low Back Pain. Spine 39:7, pages 556-563.
Crossref
Crossref
Ferdi Yavuz. (2014) Diagnosis and pharmacologic management of neuropathic pain among patients with chronic low back pain. World Journal of Rheumatology 4:3, pages 54.
Crossref
Crossref
Edward Michna, Wendy Y. Cheng, Caroline Korves, Howard Birnbaum, Ryan Andrews, Zhou Zhou, Ashish V. Joshi, David Schaaf, Jack Mardekian & Mei Sheng. (2014) Systematic Literature Review and Meta-Analysis of the Efficacy and Safety of Prescription Opioids, Including Abuse-Deterrent Formulations, in Non-Cancer Pain Management. Pain Medicine 15:1, pages 79-92.
Crossref
Crossref
Howard S. Smith & Andras Laufer. (2014) Opioid induced nausea and vomiting. European Journal of Pharmacology 722, pages 67-78.
Crossref
Crossref
Marko Obradovic, Arun Lal & Hiltrud Liedgens. (2013) Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health and Quality of Life Outcomes 11:1.
Crossref
Crossref
Deepti Jain & Pawan Kumar Basniwal. (2013) Tapentadol, a novel analgesic: Review of recent trends in synthesis, related substances, analytical methods, pharmacodynamics and pharmacokinetics. Bulletin of Faculty of Pharmacy, Cairo University 51:2, pages 283-289.
Crossref
Crossref
R. Viganò, A. Fanelli, D. Ghisi, G. Danelli & S. E. De Martinis. (2013) Il controllo del dolore nelle protesi totali di ginocchioManagement of pain after total knee replacement. LO SCALPELLO-OTODI Educational 27:3, pages 147-152.
Crossref
Crossref
Timothy J. Atkinson, Jeffrey Fudin, Abhinetri Pandula & Maira Mirza. (2013) Medication Pain Management in the Elderly: Unique and Underutilized Analgesic Treatment Options. Clinical Therapeutics 35:11, pages 1669-1689.
Crossref
Crossref
Michael Camilleri. (2013) Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. Journal of Clinical Investigation 123:10, pages 4111-4120.
Crossref
Crossref
M. Soledad Cepeda, Daniel Fife, Qianli Ma & Patrick B. Ryan. (2013) Comparison of the Risks of Opioid Abuse or Dependence Between Tapentadol and Oxycodone: Results From a Cohort Study. The Journal of Pain 14:10, pages 1227-1241.
Crossref
Crossref
Ilona Steigerwald, Michael Schenk, Uwe Lahne, Peter Gebuhr, Dietmar Falke & Barbara Hoggart. (2013) Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain. Clinical Drug Investigation 33:9, pages 607-619.
Crossref
Crossref
Gyanprakash A. Ketwaroo, Vivian Cheng & Anthony Lembo. (2013) Opioid-Induced Bowel Dysfunction. Current Gastroenterology Reports 15:9.
Crossref
Crossref
Hélène Cawston, Alison Davie, Marie-Ange Paget, Vladimir Skljarevski & Michael Happich. (2013) Efficacy of duloxetine versus alternative oral therapies: an indirect comparison of randomised clinical trials in chronic low back pain. European Spine Journal 22:9, pages 1996-2009.
Crossref
Crossref
Luis Enrique Chaparro, Andrea D Furlan, Amol Deshpande, Angela Mailis-Gagnon, Steven Atlas & Dennis C Turk. (2013) Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Bart Morlion. (2013) Chronic low back pain: pharmacological, interventional and surgical strategies. Nature Reviews Neurology 9:8, pages 462-473.
Crossref
Crossref
Martin Strohmeier, Susanne Waldmann-Rex & Karla Schwenke. (2013) Einfluss von Tapentadol retard auf die Funktionalität bei starken chronischen SchmerzenInfluence of tapentadol retard on functional parameters in patients with severe chronic pain — Is there a benefit in daily life?. MMW - Fortschritte der Medizin 155:S4, pages 63-71.
Crossref
Crossref
Suzanne K. Vosburg, Jermaine D. Jones, Jeanne M. Manubay, Judy B. Ashworth, Douglas Y. Shapiro & Sandra D. Comer. (2013)
A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin
®
(non-TRF) in prescription opioid abusers
. Addiction 108:6, pages 1095-1106.
Crossref
Crossref
kat. (2013) Schmerzen effektiv lindern. Der Hausarzt 50:10, pages 60-60.
Crossref
Crossref
Sanjay Merchant, Les L. Noe, Andrew Howe, Steve Duff, Joe Gricar, Kristine Ogden & Samir H. Mody. (2013) Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain. Clinical Therapeutics 35:5, pages 659-672.
Crossref
Crossref
Daniel Ostertag & Matthias Strittmatter. (2013) Was hilft beim brennenden Schmerz?. DNP - Der Neurologe und Psychiater 14:4, pages 40-48.
Crossref
Crossref
Jan Gaertner & Christine Schiessl. (2013) Cancer Pain Management: What’s New?. Current Pain and Headache Reports 17:4.
Crossref
Crossref
Rafael Gálvez, Michael Schäfer, Guy Hans, Dietmar Falke & Ilona Steigerwald. (2013) Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study. Advances in Therapy 30:3, pages 229-259.
Crossref
Crossref
Donghu Bai, Sha‐Hua Huang, Zuming Lin, Lin Yang, Junzeng Dai, Meng‐Yuan Huang, Xueshun Jia & Ran Hong. (2013) Aza‐Belluš‐Claisen Rearrangement‐Enabled Synthesis of Racemic Tapentadol and Its Stereoisomers. Chinese Journal of Chemistry 31:3, pages 317.
Crossref
Crossref
Asbjørn M. Drewes, Rasmus D. Jensen, Lecia M. Nielsen, Joanne Droney, Lona L. Christrup, Lars Arendt-Nielsen, Julia Riley & Albert Dahan. (2013) Differences between opioids: pharmacological, experimental, clinical and economical perspectives. British Journal of Clinical Pharmacology 75:1, pages 60-78.
Crossref
Crossref
Robert Taylor, Joseph V. Pergolizzi & Robert B. Raffa. (2013) Tapentadol Extended Release for Chronic Pain Patients. Advances in Therapy 30:1, pages 14-27.
Crossref
Crossref
M. Merker, G. Dinges, T. Koch, P. Kranke & A.M. Morin. (2012) Erratum zu: Unerwünschte Nebenwirkungen von Tapentadol im Vergleich zu OxycodonErratum to: Undesired side effects of tapentadol in comparison to oxycodone. Der Schmerz 26:6, pages 724-725.
Crossref
Crossref
M. Kim & G. Vorsanger. (2012) Letter: effects of oxycodone and tapentadol dosage on gastrointestinal function. Alimentary Pharmacology & Therapeutics 36:7, pages 688-688.
Crossref
Crossref
Richard B Silverman, Keith A CandiottiMelvin C Gitlin. (2012) Tapentadol extended-release: a recent addition to our analgesic armamentarium. Pain Management 2:5, pages 451-456.
Crossref
Crossref
M. Giorgi, A. Meizler & P.C. Mills. (2012) Quantification of tapentadol in canine plasma by HPLC with spectrofluorimetric detection: Development and validation of a new methodology. Journal of Pharmaceutical and Biomedical Analysis 67-68, pages 148-153.
Crossref
Crossref
Christine Starostzik & Ulrike Maronde. (2012) Linderung akuter und chronischer Rückenschmerzen. CME 9:7-8, pages 42-44.
Crossref
Crossref
I. D. Jeong, M. Camilleri, A. Shin, J. Iturrino, A. Boldingh, I. Busciglio, D. Burton, M. Ryks, D. Rhoten & A. R. Zinsmeister. (2012) A randomised, placebo‐controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Alimentary Pharmacology & Therapeutics 35:9, pages 1088-1096.
Crossref
Crossref
Joseph Pergolizzi, Cayetano Alegre, David Blake, Jaime Calvo Alén, Roberto Caporali, Hans‐Raimund Casser, Gerardo Correa‐Illanes, Pedro Fernandes, Eugenio Galilea, Richard Jany, Anthony Jones, Othmane Mejjad, Jadranka Morovic‐Vergles, Ángel Oteo Álvaro, Francisco J. Radrigán Araya, Maria Eugénia C. Simões & Generoso Uomo. (2011) Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol. Pain Practice 12:4, pages 290-306.
Crossref
Crossref
Qiang Zhang, Jian-Feng Li, Guang-Hui Tian, Rong-Xia Zhang, Jin Sun, Jin Suo, Xin Feng, Du Fang, Xiang-Rui Jiang & Jing-Shan Shen. (2012) A practical and enantioselective synthesis of tapentadol. Tetrahedron: Asymmetry 23:8, pages 577-582.
Crossref
Crossref
Marko Obradovic, Robert Ikenberg, Nadine Hertel, Fernando Antoñanzas, Rafael Gálvez & Hiltrud Liedgens. (2012) Cost-Effectiveness of Tapentadol in Severe Chronic Pain in Spain: A Cost Analysis of Data From RCTs. Clinical Therapeutics 34:4, pages 926-943.
Crossref
Crossref
Victor Mendis. (2012) Role of tapentadol in pain management. British Journal of Hospital Medicine 73:3, pages 143-147.
Crossref
Crossref
Sheridan M. Hoy. (2012) Tapentadol Extended Release. Drugs 72:3, pages 375-393.
Crossref
Crossref
Andrew R. Moore, Sebastian Straube, Christopher Eccleston, Sheena Derry, Dominic Aldington, Philip Wiffen, Rae F. Bell, Katri Hamunen, Ceri Phillips & Henry McQuay. (2012) Estimate at your peril: Imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain 153:2, pages 265-268.
Crossref
Crossref
M. Merker, G. Dinges, T. Koch, P. Kranke & A.M. Morin. (2012) Unerwünschte Nebenwirkungen von Tapentadol im Vergleich zu OxycodonUndesired side effects of tapentadol in comparison to oxycodone. Der Schmerz 26:1, pages 16-26.
Crossref
Crossref
M. Soledad Cepeda, Alex Sutton, Rachel Weinstein & Myoung Kim. (2012) Effect of Tapentadol Extended Release on Productivity. The Clinical Journal of Pain 28:1, pages 8-13.
Crossref
Crossref
M Camilleri. (2011) Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome. Clinical Pharmacology & Therapeutics 91:1, pages 44-59.
Crossref
Crossref
&NA;. (2011) Tapentadol immediate- and extended-release: a guide to its use in acute and chronic pain. Drugs & Therapy Perspectives 27:12, pages 1-6.
Crossref
Crossref
Chris Pasero. (2011) Tapentadol for Multimodal Pain Management. Journal of PeriAnesthesia Nursing 26:5, pages 343-346.
Crossref
Crossref
Mario Andrés Leotau Rodríguez. (2011) Tapentadol, una nueva opción terapéutica. Revista Colombiana de Anestesiología 39:3, pages 375-385.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Supportive & Palliative Care 5:2, pages 174-183.
Crossref
Crossref
Craig T. Hartrick & Richard J. Rozek. (2011) Tapentadol in Pain Management. CNS Drugs 25:5, pages 359-370.
Crossref
Crossref
Michael Camilleri. (2011) Opioid-Induced Constipation: Challenges and Therapeutic Opportunities. American Journal of Gastroenterology 106:5, pages 835-842.
Crossref
Crossref
Mila Etropolski, Kathleen Kelly, Akiko Okamoto & Christine Rauschkolb. (2011) Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride. Advances in Therapy 28:5, pages 401-417.
Crossref
Crossref
Michael Camilleri, Margaret Rothman, Kai Fai Ho & Mila Etropolski. (2011) Validation of a Bowel Function Diary for Assessing Opioid-Induced Constipation. American Journal of Gastroenterology 106:3, pages 497-506.
Crossref
Crossref
Uwe Fricke & Ulrich Schwabe. 2011. Arzneiverordnungs-Report 2011. Arzneiverordnungs-Report 2011
43
117
.
Monika Thomm. 2012. Schmerzmanagement in der Pflege. Schmerzmanagement in der Pflege
23
90
.
Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro, Akiko Okamoto, Robert Lange, Juergen Haeussler & Christine Rauschkolb. (2010) Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Current Medical Research and Opinion, pages 151-162.
Crossref
Crossref
Vaughn E. Nossaman, Usha Ramadhyani, Philip J. Kadowitz & Bobby D. Nossaman. (2010) Advances in Perioperative Pain Management: Use of Medications with Dual Analgesic Mechanisms, Tramadol & Tapentadol. Anesthesiology Clinics 28:4, pages 647-666.
Crossref
Crossref